Literature DB >> 32641783

Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil.

Pedro C Hallal1, Cesar G Victora2, Mariângela F Silveira2, Aluísio J D Barros2, Bernardo L Horta2, Lúcia C Pellanda3, Gabriel D Victora4, Odir A Dellagostin2, Claudio J Struchiner5, Marcelo N Burattini6, Andréia R M Valim7, Evelise M Berlezi8, Jeovany M Mesa9, Maria Letícia R Ikeda10, Marilia A Mesenburg3, Marina Mantesso11, Marinel M Dall'Agnol12, Raqueli A Bittencourt13, Fernando P Hartwig2, Ana M B Menezes2, Fernando C Barros2.   

Abstract

Population-based data on COVID-19 are urgently needed. We report on three rounds of probability sample household surveys in the state of Rio Grande do Sul (Brazil), carried out in nine large municipalities using the Wondfo lateral flow point-of-care test for immunoglobulin M and G antibodies against SARS-CoV-2 (https://en.wondfo.com.cn/product/wondfo-sars-cov-2-antibody-test-lateral-flow-method-2/). Before survey use, the assay underwent four validation studies with pooled estimates of sensitivity (84.8%; 95% confidence interval (CI) = 81.4-87.8%) and specificity (99.0%; 95% CI = 97.8-99.7%). We calculated that the seroprevalence was 0.048% (2/4,151; 95% CI = 0.006-0.174) on 11-13 April (round 1), 0.135% (6/4,460; 95% CI = 0.049-0.293%) on 25-27 April (round 2) and 0.222% (10/4,500; 95% CI = 0.107-0.408) on 9-11 May (round 3), with a significant upward trend over the course of the surveys. Of 37 family members of positive individuals, 17 (35%) were also positive. The epidemic is at an early stage in the state, and there is high compliance with social distancing, unlike in other parts of Brazil. Periodic survey rounds will continue to monitor trends until at least the end of September, and our population-based data will inform decisions on preventive policies and health system preparedness at the state level.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32641783     DOI: 10.1038/s41591-020-0992-3

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  52 in total

Review 1.  The emergence, genomic diversity and global spread of SARS-CoV-2.

Authors:  Juan Li; Shengjie Lai; George F Gao; Weifeng Shi
Journal:  Nature       Date:  2021-12-08       Impact factor: 49.962

2.  Social distancing patterns in nine municipalities of Rio Grande do Sul, Brazil: the Epicovid19/RS study.

Authors:  Aluisio J D Barros; Cesar G Victora; Ana M B Menezes; Bernardo L Horta; Fernando Hartwig; Gabriel Victora; Lúcia C Pellanda; Odir A Dellagostin; Claudio J Struchiner; Marcelo N Burattini; Marcelo R Gonçalves; Lia G Possuelo; Liliana P Weber; Sonara Lucia Estima; Nadège Jacques; Jenifer Härter; Shana G Silva; Matias Frizzo; Rosangela C Lima
Journal:  Rev Saude Publica       Date:  2020-07-24       Impact factor: 2.106

3.  Seroprevalence of SARS-CoV-2 antibodies in South Korea.

Authors:  Kwangmin Lee; Seongil Jo; Jaeyong Lee
Journal:  J Korean Stat Soc       Date:  2021-05-24       Impact factor: 0.805

4.  Attack rate and the price of SARS-CoV-2 herd immunity in Brazil.

Authors:  Tarcisio Rocha Filho; José Mendes; Carson Chow; James Phillips; Antônio Cordeiro; Fulvio Scorza; Antonio-Carlos Almeida; Marcelo Moret
Journal:  Res Sq       Date:  2021-07-08

5.  Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city.

Authors:  Om Prakash; Bhavin Solanki; Jay Sheth; Divyang Oza; Mina Kadam; Sheetal Vyas; Aparajita Shukla; Jayshri Pethani; Hemant Tiwari
Journal:  J Family Med Prim Care       Date:  2021-07-02

6.  AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.

Authors:  Bijon Kumar Sil; Mohd Raeed Jamiruddin; Md Ahsanul Haq; Mohib Ullah Khondoker; Nowshin Jahan; Shahad Saif Khandker; Tamanna Ali; Mumtarin Jannat Oishee; Taku Kaitsuka; Masayasu Mie; Kazuhito Tomizawa; Eiry Kobatake; Mainul Haque; Nihad Adnan
Journal:  Int J Nanomedicine       Date:  2021-07-09

7.  Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.

Authors:  Edson Zangiacomi Martinez; Afonso Dinis Costa Passos; Amaury Lelis Dal Fabbro; Anderson Soares da Silva; Andreia Cássia Escarso; Antônio Pazin-Filho; Benedito Antônio Lopes da Fonseca; Benedito Carlos Maciel; Daniel Cardoso de Almeida E Araújo; Diego Villa Clé; Gilberto Gambero Gaspar; Jair Lício Ferreira Dos Santos; Janise Braga Barros Ferreira; João Paulo Souza; Luane Marques de Mello; Luciane Loures Dos Santos; Luzia Márcia Romanholi Passos; Márcio Junio Lima Siconelli; Ricardo de Carvalho Cavalli; Rodrigo de Carvalho Santana; Rodrigo do Tocantins Calado; Sandro Scarpelini; Valdes Roberto Bollela; Vitor Gonçalves Floriano; Fernando Bellissimo-Rodrigues
Journal:  Rev Soc Bras Med Trop       Date:  2021-07-02       Impact factor: 1.581

8.  Did Laos really control the transmission of SARS-CoV-2 in 2020?

Authors:  Barnaby Flower; Michael Marks
Journal:  Lancet Reg Health West Pac       Date:  2021-07-20

9.  Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  medRxiv       Date:  2020-07-31

10.  High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

Authors:  Susy Fanny Núñez-Zapata; Bruno Benites-Peralta; Percy Mayta-Tristan; Alfonso J Rodríguez-Morales
Journal:  Int J Infect Dis       Date:  2021-07-11       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.